Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2426361rdf:typepubmed:Citationlld:pubmed
pubmed-article:2426361lifeskim:mentionsumls-concept:C0042776lld:lifeskim
pubmed-article:2426361lifeskim:mentionsumls-concept:C0003250lld:lifeskim
pubmed-article:2426361lifeskim:mentionsumls-concept:C0205419lld:lifeskim
pubmed-article:2426361lifeskim:mentionsumls-concept:C2076600lld:lifeskim
pubmed-article:2426361lifeskim:mentionsumls-concept:C0205369lld:lifeskim
pubmed-article:2426361lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:2426361lifeskim:mentionsumls-concept:C1705294lld:lifeskim
pubmed-article:2426361pubmed:issue4lld:pubmed
pubmed-article:2426361pubmed:dateCreated1986-9-17lld:pubmed
pubmed-article:2426361pubmed:abstractTextA panel of monoclonal antibodies specific for a corresponding panel of sequentially selected variants of influenza A/PR/8/34 virus has been established. Although the monoclonal antibodies are paratypically distinct, idiotypic relatedness has been observed. Two cross-reactive idiotypes have been defined that are associated with the 7183 and S107 VH gene families, respectively. Three of the four monoclonal antibodies utilize the VK21 group of light chains, and three VH genes belong to the VH7183 family and one to the VH S107 family. Antibodies encoded by genes deriving from the VH7183 family share a cross-reactive idiotype, a marker of the VH region as well as distinct individual idiotopes. These antibodies are produced by different clones using related VH and VK genes.lld:pubmed
pubmed-article:2426361pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2426361pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2426361pubmed:languageenglld:pubmed
pubmed-article:2426361pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2426361pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2426361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2426361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2426361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2426361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2426361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2426361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2426361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2426361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2426361pubmed:statusMEDLINElld:pubmed
pubmed-article:2426361pubmed:monthAuglld:pubmed
pubmed-article:2426361pubmed:issn0022-1767lld:pubmed
pubmed-article:2426361pubmed:authorpubmed-author:SchulmanJ LJLlld:pubmed
pubmed-article:2426361pubmed:authorpubmed-author:NortonGGlld:pubmed
pubmed-article:2426361pubmed:authorpubmed-author:BonaC ACAlld:pubmed
pubmed-article:2426361pubmed:authorpubmed-author:MoranT MTMlld:pubmed
pubmed-article:2426361pubmed:authorpubmed-author:ManheimerA...lld:pubmed
pubmed-article:2426361pubmed:authorpubmed-author:RealeM AMAlld:pubmed
pubmed-article:2426361pubmed:issnTypePrintlld:pubmed
pubmed-article:2426361pubmed:day15lld:pubmed
pubmed-article:2426361pubmed:volume137lld:pubmed
pubmed-article:2426361pubmed:ownerNLMlld:pubmed
pubmed-article:2426361pubmed:authorsCompleteYlld:pubmed
pubmed-article:2426361pubmed:pagination1352-8lld:pubmed
pubmed-article:2426361pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:2426361pubmed:meshHeadingpubmed-meshheading:2426361-...lld:pubmed
pubmed-article:2426361pubmed:meshHeadingpubmed-meshheading:2426361-...lld:pubmed
pubmed-article:2426361pubmed:meshHeadingpubmed-meshheading:2426361-...lld:pubmed
pubmed-article:2426361pubmed:meshHeadingpubmed-meshheading:2426361-...lld:pubmed
pubmed-article:2426361pubmed:meshHeadingpubmed-meshheading:2426361-...lld:pubmed
pubmed-article:2426361pubmed:meshHeadingpubmed-meshheading:2426361-...lld:pubmed
pubmed-article:2426361pubmed:meshHeadingpubmed-meshheading:2426361-...lld:pubmed
pubmed-article:2426361pubmed:meshHeadingpubmed-meshheading:2426361-...lld:pubmed
pubmed-article:2426361pubmed:meshHeadingpubmed-meshheading:2426361-...lld:pubmed
pubmed-article:2426361pubmed:meshHeadingpubmed-meshheading:2426361-...lld:pubmed
pubmed-article:2426361pubmed:meshHeadingpubmed-meshheading:2426361-...lld:pubmed
pubmed-article:2426361pubmed:meshHeadingpubmed-meshheading:2426361-...lld:pubmed
pubmed-article:2426361pubmed:meshHeadingpubmed-meshheading:2426361-...lld:pubmed
pubmed-article:2426361pubmed:meshHeadingpubmed-meshheading:2426361-...lld:pubmed
pubmed-article:2426361pubmed:meshHeadingpubmed-meshheading:2426361-...lld:pubmed
pubmed-article:2426361pubmed:year1986lld:pubmed
pubmed-article:2426361pubmed:articleTitleCharacterization of monoclonal antibodies specific for sequential influenza A/PR/8/34 virus variants.lld:pubmed
pubmed-article:2426361pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2426361pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2426361pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2426361lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2426361lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2426361lld:pubmed